PhagoMed Biopharma
Develops endolysins and phage as therapeutics.
Launch date
Employees
Market cap
-
Enterprise valuation
$7—10m (Dealroom.co estimates Jun 2019.)
Company register number FN 481174i
Vienna Austria (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €4.0m | Seed | |
| N/A | $1.7m | Seed | |
N/A | Grant | ||
€20.0k | Grant | ||
N/A | Acquisition | ||
| Total Funding | $6.1m | ||
Recent News about PhagoMed Biopharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.